ArticleFrontiers in oncology2023

Tislelizumab immunotherapy combined with chemotherapy in the treatment of a patient with primary anterior mediastinal undifferentiated pleomorphic sarcoma with high PD-L1 expression: A case report and literature review.

Hujuan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.